Max Health is happy to announce the approval of TapClob Oral suspension for registration for use in New Zealand, as advised by Medsafe. This is effective as of 27/02/2020 and applies to both concentrations of 5mg/mL and 10mg/mL. This product is manufactured in the UK. It is supplied to Max Health by Ethypharm UK.